51. Jouanneau, E., Black, K.L., Veiga, L., Goverdhana, S., Gragg, A., Zandian, M., Zhai, Y., Zhang, X-x., Mardiros, A., Wang, H.-Q., Panwar, A., Irvin, D., and Wheeler, C. J. Intrinsically de-sialylated CD103(+) CD8 T cells mediate beneficial anti-glioma immune responses. June 2014, Cancer Immunology, Immunotherapy.

50. Wheeler C, Wu H, Sarayba D, Gragg A, Siegel E, Thomas D, Andres E, Thompson K, Black KL, Pechnick P, IrvinD, T-lymphocytes influence behavioral deficits in the 6-OHDA unilateral lesion model for Parkinson’s disease. July 2014, Journal of Neurology & Neurophysiology.

49. Junes-Gill KS, Lawrence CE, Wheeler CJ, Cordner R, Gill TG, Mar V, Shiri L, Basile LA. “Human Hematopoietic Signal peptide-containing Secreted 1 (hHSS1) modulates genes and pathways in glioma: implications for the regulation of tumorigenicity and angiogenesis”, BMC Cancer 14:920 (2014).

48. Jouanneau E, Black KL, Veiga L, Cordner R, Goverdhana, S, Zhai Y, Zhang X, Panwar A, Mardiros A, Wang HQ, Gragg A, Zandian M, Irvin D, and Wheeler CJ “Intrinsically desialyated CD103+ CD8 T cells mediate beneficial anti-glioma immune responses”, Cancer Immunol Immunother 63:911-24 (2014)

47. Wheeler CJ, Seksenyan A, Koronyo Y, Rentsendorj A, Sarayba D, Wu H, Gragg A, Siegel E, Thomas D, Espinosa A, Thompson K, Black K, Koronyo-Hamaoui M, Pechnick R, and Irvin DK “T-lymphocyte deficiency exacerbates behavioural deficits in the 6-OHDA unilateral lesion rat model for Parkinson’s Disease”, J Neurol Neurophysiol 5(3). pii: 209. (2014)

46. Cordner, R., Black, K.L., and Wheeler, C.J. (2013) The exploitation of adaptive evolution to treat glioblastoma multiforme CNS Oncology 2:171-179.

45. Niesen CE, Xu J, Fan X, Li X, Wheeler CJ, Mamelak AN, Wang C. “Transcriptomic profiling of human peritumoral neocortex tissues revealed genes possibly involved in tumorinduced epilepsy”, PLoS ONE 8(2):e56077 (2013) PMID: 23418513

44. Phuphanich S*, Wheeler CJ*, Rudnick JD, Mazer M, Wang H, Nuño MA, Richardson JE, Fan X, Ji J, Chu RM, Bender JG, Hawkins ES, Patil CG, Black KL, Yu JS. “Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma”, Cancer Immunol Immunother 62:125-35 (2013) PMID: 2284702 *equal contributors

43. Patil C, Yi A, Elramsisy A, Hu J, Mukherjee D, Irvin D, Yu J, Bannykh S, Black K, Nuño M. Prognosis of Patients with Multifocal Glioblastoma: A Case-Controlled Study. March 2012. Journal of Neurosurgery

42. Wheeler CJ, Black KL. (2011) Vaccines for glioblastoma and high-grade glioma Expert Rev Vaccines 10:875-86.

41. Junes-Gill KS, Gallaher TK, Gluzman-Poltorak Z, Miller JD, Wheeler CJ, Fan X, Basile LA. hHSS1: a novel secreted factor and suppressor of glioma growth located at chromosome 19q13.33. J Neurooncol. 102:197-211 (2011).

40. Irvin DK, Jouanneau E, Duvall G, Zhang X, Zhai y, Sarayba D, Seksenyan A, Panwar A, Black KL, Wheeler CJ. T cell activity promotes stem-like properties, but not malignancy, in gliomas. 2010, PlosOne, Jun 7;5(6):e10974.

39. Irvin, D., Duvall, G., Zhang, X-x., Zhai, Y., Sarayba, D., Seksenyan, A., Panwar, A., Black, K.L., and Wheeler, C. J. “T cells enhance stem-like properties and conditional malignancy in gliomas”, PlosONE 5 e10974 (2010)

38. Wheeler, C. J., and K. L. Black. (2009) DCVax-Brain and DC vaccines in the treatment of GBM. Expert Opin Investig Drugs 18:509.

37. Wheeler C, Black K, Liu G, Wagenberg M, Zhang X, Pepkowitz S, Goldfinger D, Ng H, Irvin D, K Yu J. Vaccination with tumor lysate-pulsed dendritic cells elicits correlated immune and clinical response magnitudes in patients with glioblastoma multiforme. 2008 Cancer Research, Jul 15;68 (14):5955-64.

36. Black K, Yin D, Konda B, Wang X, Hu J, Ko M, Bayan J, Sacapano M, Espinoza A, Ong J, Irvin D, Shu Y, Different Effects of KCa and KATP Agonists on Brain Tumor Permeability between Syngeneic and Allogeneic Rat Models. 2008, Brain Research Aug 28;1227:198-206 (Selected as Cover Article).

35. Black K, Yin D, Ong J, Hu J, Konda B, Wang X, Ko M, Bayan J, Sacapano M, Espinoza A, Irvin DK, Shu Y. Phosphodiesterase 5 Inhibitors Enhance Tumor Permeability and Efficacy of Chemotherapy in a Rat Brain Tumor Model, 2008 Brain Research, Sept. 1230:290-302.

34. Irvin DK, Thompson L, Kirik D, Björklund A In Vivo Gene Delivery to Endogenous Striatal Progenitors Generated by a 6-hydroxydopamine Lesion of the Nigrostriatal Dopamine Pathway. 2008 Neurobiology of Disease. Jun; 30(3):343-52 (Selected as Cover Article).

33. Yin D, Wang X, Konda B, Ong J, Hu J, Sacapano M, Ko M, Espinoza A, Irvin DK, Shu Y, Black K. Increase in Brain Tumor Permeability in Glioma-bearing Rats with Nitric Oxide Donors. 2008 Clinical Cancer Research, Jun 15;14(12):4002-9.

32. Wheeler, C. J., K. L. Black, G. Liu, M. Wagenberg, X.-x. Zhang, S. Pepkowitz, D. Goldfinger, H. Ng, D. Irvin, and J. S. Yu. “Vaccination elicits correlated immune and clinical responses in patients with glioblastoma multiforme”, Cancer Res 68:5955-5964 (2008)

31. *Ghods-Jourabchi A, *Irvin DK, Gentao Liu G, Abdulkadir I, Yuan X, Tunici P, Wachsmann-Hogi S, Konda B, Black K, Yu J, Spheres Isolated from 9L Gliosarcoma Rat Cell Line Possess Chemoresistant and Aggressive Cancer Stem-Like Cells. 2007 Stem Cells Jul;25(7):1645-53

30. Hu J, Yuan X, Ko MK, Yin D, Sacapano MR, Wang X, Konda BM, Espinoza A, Prosolovich K, Ong JM, Irvin DK, Black KL. Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. 2007 Molecular Cancer. Mar 14;6:22.

29. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin DK, Black KL, Yu JS. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. 2006 Molecular Cancer. Dec 2; 5:67.

28. Andersson E, Irvin DK, Ahlsiö J Parmar M. Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells. Experimental Cell Research. Apr 1; 313(6):1172-80

27. Tunici P, Irvin DK, Liu G, Yuan X, Zhaohui Z, Ng H, Yu J, Brain Tumor Stem Cells: New Targets for Clinical Treatments. Neurosurgical Focus 20(4) E27, 2006.

26. Irvin DK, Yuan X, Tunici P, Yu JS. Neural Stem Cells – A Promising Potential Therapy for Brain Tumors. 2006 Current Stem Cell Research & Therapy.

25. Wheeler, C.J., and Black, K. (2005) Dendritic Cell Vaccines and Obstacles to Beneficial Immunity in Glioma Patients. Current Opinion Mol Ther 7:35-47.

24. Wheeler, C.J., and Black, K.L. (2005) Vaccines and beneficial immunity in glioma patients. Front Biosc 10:2861-2881

23. Liu, G., Akasaki, Y., Khong, H.T., Wheeler, C.J., Das, A., Black, K.L., and Yu, J.S. “Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy”, Oncogene 24:5226-5234 (2005)

22. Wheeler, C.J., Yu, J., and Black, K.L. (2004) Cellular immunity in the treatment of brain tumors. Clinical Neurosurgery 51:132-139.

21. Wheeler, C.J., Das, A., Liu, G., Yu, J.S., and Black, K. “ Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination”, Clin Cancer Res 10:5316-5326 glioblastoma multiforme to chemotherapy after vaccination”, Clin Cancer Res 10:5316-5326-2004

20. Yu, J.S., Liu, G., Ying, H., Yong, W.H., Black, K.L., and Wheeler, C.J. “Vaccination with tumor lysate-pulsed dendritic cells elicits specific cytotoxic T cells in patients with malignant glioma”, Cancer Res 64:4973-4979 (2004)

19. Liu, G., Ying, H., Zeng, G., Dudley, M.E., Wheeler, C.J., Black, K.L., and Yu, J.S. “HER-2, gp100 and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic Tcells”, Cancer Res 64:4980-4986 (2004)

18. Prins, R.M.*, Incardona, F.*, Lau, R., Lee, P.K., Black, K.L., Claus, S., Zhang, W., and Wheeler, C.J. “Characterization of defective CD4-8- T cells in murine tumors generated Wheeler, C.J. “Characterization of defective CD4-8- T cells in murine tumors generated independent of antigen specificity” J Immunol 172, 1602-1611 (2004) *equal contributors

17. Irvin DK, Nakano I, Paucar AA, Kornblum HI. Patterns of Jagged1, Jagged2, Delta-like 1 and Delta-like 3 expression during late embryonic and postnatal brain development suggests multiple functional roles in progenitors and differentiated cells. 2004 Journal of Neuroscience Research 75(3): 330-4

16. Easterday MC, Dougherty JD, Jackson RL, Ou J, Nakano I, Paucar AA, Roobini B, Dianati M, Irvin DK, Weissman IL, Terskikh AV, Geschwind DH, Kornblum HI. Neural progenitor genes. Germinal zone expression and analysis of genetic overlap in stem cell populations. 2003 Developmental Biology 264(2): 309-22.

15. Wheeler, C.J., Black, K.L., Liu, G., Gutierrez, M., Ying, H., Yu, J.S., Zhang, W., and Lee, P.K. “Thymic CD8+ T cell production strongly influences tumor antigen recognition and agedependent glioma mortality”, J Immunol 171, 4927-4933 (2003)

14. Liu, G., Khong, H.T., Wheeler, C.J., Yu, J.S., Black, K.L., and Ying, H. “Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma”, J Immunother 26, 301-312 (2003)

13. Prins, R.M., Graf, M.R., Merchant, R.E., Black, K.L., and Wheeler , C.J. “Deficits in thymic function and output of recent thymic emigrant T cells during intracranial glioma function and output of recent thymic emigrant T cells during intracranial glioma progression”, J Neuro-oncol 64, 45-54 (2003)

12. Yu, J.S., Lee, P.K., Ehtesham, M., Samoto, K., Black, K.L., and Wheeler, C.J. “Intratumoral T cell subset ratios and fas ligand expression on brain tumor endotheliu”, J Neuro-oncol 64, 55-61 (2003)

11. Irvin DK, Dhaka A, Hicks C, Weinmaster G, Kornblum HI. Extrinsic and intrinsic factors governing cell fate in cortical progenitor cultures. 2003 Developmental Neuroscience 25(2-4):162-72.

10. Dhaka A, Costa RM, Hu H, Irvin DK, Patel A, Kornblum HI, Silva AJ, O’Dell TJ, Colicelli J. The RAS effector RIN1 modulates the formation of aversive memories. 2002 Journal of Neuroscience 23(3):748-57.

9. Liu, Y., Ehtesham, M., Samoto, K., Wheeler, C.J., Thompson, R.C., Villareal, L.P., Black, cytotoxic immunity in glioma. Cancer Gene Therapy 9: 9-15 (2002)

8. Irvin DK, Zurcher SD, Nguyen T, Weinmaster G, Kornblum HI. Expression patterns of Notch1, Notch2, and Notch3 suggest multiple functional roles for the Notch-DSL signaling system during brain development. 2001 Journal of Comparative Neurology 436(2): 167-81.

7. Kinoshita Y, Jarell AD, Flaman JM, Foltz G, Schuster J, Sopher BL, Irvin DK, Kanning K, Kornblum HI, Nelson PS, Hieter P, Morrison RS. Pescadillo, a novel cell cycle regulatory protein abnormally expressed in malignant cells. 2001 Journal of Biological Chemistry 276(9): 6656-65.

6. Yu, J., Wheeler, C.J., Lee, P.K., Prins, R., Lau, R., Zhang, W., Zeltzer, P., and Black, K.L. “ Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration”, Cancer Res 61, 842-847 (2001)

5. Wheeler, C.J., Chen, J.-Y., Potter, T., and Parnes, J.R. “Mechanisms of CD8?-mediated Tcell response enhancement: Interaction with MHC class I/?2-microglobulin and functional cell response enhancement: Interaction with MHC class I/?2-microglobulin and functional coupling to TCR/CD3”, J. Immunol. 160, 4199-4207 (1998)

4. Wheeler, C.J., von Hoegen, P., and Parnes, J.R. “An immunological role for the CD8?-chain”, Nature 357, 247-249 (1992)

3. Wheeler, C.J., Maloney, D., Fogel, S., and Goodenow, R.S. “Microconversion between murine MHC class I genes integrated into yeast”, Nature 347, 192-194 (1990)

2. Watts, S., Cranmer Davis, A., Gaut, B., Wheeler, C., Hill, L., and Goodenow, R.S. “Organization and structure of the Qa genes of the major histocompatibility complex of the C3H mouse: implications for Qa function and class I evolution”, EMBO J. 8, 1749-1759 (1989)

1. Watts, S., Wheeler, C., Morse, R., and Goodenow, R.S. “Amino acid comparison of the class I antigens of mouse major histocompatibility complex”, Immunogenetics 30, 390-392 (1989)